Prospective evaluation of an Australian pertussis toxin IgG and IgA enzyme immunoassay

Clinical and Vaccine Immunology

Volumn 19, Issue 2, 2012, Pages 190-197

  May, Meryta L ^a   Doi, Suhail A ^b   King, David ^b   Evans, Jenny ^a   Robson, Jennifer M ^a  

^a Sullivan Nicolaides Pathology ^*  (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PERTUSSIS TOXIN IMMUNOGLOBULIN A; PERTUSSIS TOXIN IMMUNOGLOBULIN G; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBODY RESPONSE; ARTICLE; BORDETELLA PERTUSSIS; CHILD; CLINICAL CLASSIFICATION; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE DURATION; ENZYME IMMUNOASSAY; FEMALE; HUMAN; INTERMETHOD COMPARISON; INTERNATIONAL STANDARD UNIT; MAJOR CLINICAL STUDY; MALE; NONHUMAN; ONSET AGE; PERTUSSIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; AUSTRALIA; BORDETELLA PERTUSSIS; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INFANT; MALE; MIDDLE AGED; PERTUSSIS TOXIN; PROSPECTIVE STUDIES; SEROLOGIC TESTS; VIRULENCE FACTORS, BORDETELLA; WHOOPING COUGH; YOUNG ADULT;

EID: 84856442592     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.05430-11     Document Type: Article

References (24)

1. Andre P, et al. 2008. Comparison of serological and real-time PCR assays to diagnose Bordetella pertussis infection in 2007. J. Clin. Microbiol. 46: 1672-1677. (Pubitemid 351657212)
2. Australian Government Department of Health and Ageing. March 2004, posting date. Australian national notifiable diseases case definitions: pertussis case definition. http://www.health.gov.au/internet/main/publishing. nsf/content/cda-surveil-nndss-casedefs-cd-pertus.htm.
3. Baughman AL, et al. 2004. Establishment of diagnostic cutoff points for levels of serum antibodies to pertussis toxin, filamentous hemagglutinin, and fimbriae in adolescents and adults in the United States. Clin. Diagn. Lab. Immunol. 11:1045-1053. (Pubitemid 39540842)
4. Cagney M, MacIntyre CR, McIntyre P, Puech M, Giammanco A. 2006. The seroepidemiology of pertussis in Australia during an epidemic period. Epidemiol. Infect. 134:1208-1216. (Pubitemid 44614942)
5. de Melker HE, et al. 2000. Specificity and sensitivity of high levels of immunoglobulin G antibodies against pertussis toxin in a single serum sample for diagnosis of infection with Bordetella pertussis. J. Clin. Microbiol. 38:800-806.
6. Giammanco A, et al. 2003. European Sero-Epidemiology Network: standardisation of the assay results for pertussis. Vaccine 22:112-120. (Pubitemid 37357158)
7. Giammanco A, et al. 2008. European Sero-Epidemiology Network 2: standardisation of immunoassay results for pertussis requires homogeneity in the antigenic preparations. Vaccine 26:4486-4493.
8. Guinto-Ocampo H, Bennett JE, Attia MW. 2008. Predicting pertussis in infants. Pediatr. Emerg. Care 24:16-20. (Pubitemid 351158762)
9. Guiso N, et al. 2011. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur. J. Clin. Microbiol. Infect. Dis. 30:307-312.
10. Hallander HO, Ljungman M, Storsaeter J, Gustafsson L. 2009. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children. APMIS 117:797-807.
11. Hanley JA, McNeil BJ. 1982. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology 143:29-36. (Pubitemid 12142173)
12. Horby P, et al. 2005. A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods. Epidemiol. Infect. 133:229-236. (Pubitemid 40439302)
13. Hull BP, Mahajan D, Dey A, Menzies RI, McIntyre PB. 2010. Immunisation coverage annual report, 2008. Commun. Dis. Intell. 34:241-258.
14. Jackson LA, Cherry JD, Wang SP, Grayston JT. 2000. Frequency of serological evidence of Bordetella infections and mixed infections with other respiratory pathogens in university students with cough illnesses. Clin. Infect. Dis. 31:3-6. (Pubitemid 32268929)
15. Mattoo S, Cherry JD. 2005. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin. Microbiol. Rev. 18:326-382. (Pubitemid 40548297)
16. Menzies SL, et al. 2009. Development and analytical validation of an immunoassay for quantifying serum anti-pertussis toxin antibodies resulting from Bordetella pertussis infection. Clin. Vaccine Immunol. 16:1781-1788.
17. Pebody RG, et al. 2005. The seroepidemiology of Bordetella pertussis infection in Western Europe. Epidemiol. Infect. 133:159-171. (Pubitemid 40276986)
18. Quinn HE, McIntyre PB. 2007. Pertussis epidemiology in Australia over the decade 1995-2005 - trends by region and age group. Commun. Dis. Intell. 31:205-215.
19. Riffelmann M, Thiel K, Schmetz J, Wirsing von Koenig CH. 2010. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J. Clin. Microbiol. 48:4459-4463.
20. Tondella ML, et al. 2009. International Bordetella pertussis assay standardization and harmonization meeting report. Centers for Disease Control and Prevention, Atlanta, Georgia, United States, 19-20 July 2007. Vaccine 27:803- 814.
21. Versteegh FG, et al. 2005. Age-specific long-term course of IgG antibodies to pertussis toxin after symptomatic infection with Bordetella pertussis. Epidemiol. Infect. 133:737-748. (Pubitemid 41015566)
22. Wirsing von Konig CH, Gounis D, Laukamp S, Bogaerts H, Schmitt HJ. 1999. Evaluation of a single-sample serological technique for diagnosing pertussis in unvaccinated children. Eur. J. Clin. Microbiol. Infect. Dis. 18:341-345. (Pubitemid 29531170)
23. World Health Organization. 2001. Pertussis surveillance. World Health Organization, Geneva, Switzerland.
24. Xing D, et al. 2009. Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study. Clin. Vaccine Immunol. 16:303-311.